secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenaya Therapeutics, Inc. (TNYA)
CIK:        0001858848
Form:       8-K
Filed at:   2026-05-29T21:04:54+00:00
Accession:  0001193125-26-248680
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenaya shareholders approve amended equity plan adding 6.5M shares, elect directors
--------------------------------------------------------------------------------

- Shareholders approved amended 2021 Equity Incentive Plan with one-time increase of 6,509,966 shares (~3% of outstanding).
- Annual evergreen cap removed; future yearly increase remains 4% of outstanding shares per fiscal year.
- Class II directors Amy Burroughs, Karah Parschauer, and Catherine Stehman-Breen elected with >86M votes each.
- Deloitte & Touche ratified as independent auditor for FY2026 with 135.6M votes for.
- Plan amendments also limit shares issuable as incentive stock options to 15M total.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858848/000119312526248680/0001193125-26-248680-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858848/000119312526248680/tnya-20260527.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-248680

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer